First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

NCT00389155 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Carcinoma
Metastasis

Interventions

DRUG: Vinflunine
DRUG: Gemcitabine
OTHER: Placebo

Sponsor

Bristol-Myers Squibb